Document is current
Any future updates will be listed below
-
Authors
Cho, Hye-Yeon
Lee, Ho-Jin
Hwang, In Eob
Lee, Hyung-Chul
Kim, Won Ho
Yang, Seong-Mi
-
Funding
Funding for this research was provided by:
Seoul National University Hospital (0420210520, 0420210520, 0420210520, 0420210520, 0420210520, 0420210520)
- License Information
-
More Information
Article History
Received: 26 March 2023
Accepted: 28 September 2023
First Online: 4 November 2023
Declarations
:
: This single-center, prospective, observational study was approved by our institutional review board (IRB No.2104-037-1209) and registered on the ClinicalTrials registry (NCT04909645; date of registration: 02/06/2021). This study was conducted in accordance with the principles of the 2013 Helsinki Declaration and followed good clinical practice guidelines. Patients who underwent scheduled living-donor liver transplantation (LDLT) were enrolled between May and December 2021. All patients received both verbal and written explanations of the trial and provided written informed consent.
: Not applicable.
: The authors declare no competing interests.
